Image

Global Urinary Incontinence Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Urinary Incontinence Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Urinary Incontinence Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 10,863.30 USD Million
Diagram Market Size (Forecast Year) USD 19,088.09 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Urinary Incontinence Market, By Diagnosis (Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples), Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence), Treatment Type (Medication, Devices, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029.

Urinary Incontinence Market

Market Analysis and Size

In recent years, the urinary incontinence market is anticipated to grow rapidly during the forecast period. According to the study "Prevalence of Urinary Incontinence among Young Healthy Females in Gujarat - A Cross-sectional Study," the prevalence of UI was 71.85 percent among young women aged 18-25 years who were healthy, with 50.85 percent having stress, 9.16 percent having urge, and 40 percent having a mixed type of urinary incontinence after an 11-month study period from December 2017 to October 2018, among the total population. Several organizations are now working on devices designed specifically for women. They're launching a variety of small, tampon-like disposable devices for daily use, as well as flexible silicone rings to prevent urine leakage and support the urethra in women with vaginal prolapse.

Data Bridge Market Research analyses that the urinary incontinence market was valued at USD 10,863.3 million in 2021 and is expected to reach USD 19,088.09 million by 2029, registering a CAGR of 7.30% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Incontinence is the term for any unintentional urine leaking. Male urine incontinence is most frequently caused by a damaged sphincter or a faulty bladder. In the bladder, the sphincter is a circular muscle that controls urine flow. When the urethra, the tube that takes urine from the bladder to the outside of the body, is wounded, this muscle loses its capacity to squeeze and close it. Urinary incontinence devices help with urine collection and retention, as well as urinary incontinence management. Urinary incontinence is a condition in which pee leaks out uncontrollably.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Diseases (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Acute Bacterial Skin and Skin Structure Infections, Hospital Acquired Bacterial Pneumonia, Acquired Bacterial Pneumonia, Others), Pathogen (E. coli, P. Aeruginosa, K. Pneumoniae, Others), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination Therapies, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Zydus Cadila (India), Torrent Pharmaceuticals Ltd. (India), Apotex Inc., Eli Lilly and Company (US), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Israel), Alembic Pharmaceuticals Limited (India), Coloplast Group (Denmark), Boston Scientific Corporation (US), Alembic Pharmaceuticals Limited (India), B. Braun Melsungen AG (Germany), BD (US), Baxter (US), Johnson & Johnson Private Limited (US), Medtronic (Ireland), AstraZeneca (UK), Merck & Co., Inc. (US)

Market Opportunities

  • Increase in the number of emerging markets
  • Increase in the number of research and development activities
  • Rising investment for the development of advanced technologies
  • Surging drug approvals and launches

Urinary Incontinence Market Dynamics

Drivers

  • Rise in the prevalence of urinary incontinence

The increased prevalence of urinary incontinence is a major factor driving market expansion (UI). Urinary incontinence symptoms can be caused by a variety of reasons, including urinary tract infection, weakening of pelvic floor muscles and urethral sphincters, menopause, pregnancy, childbirth, and post-radical prostatectomy surgery in men.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of urinary incontinence market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness and increasing number of cases of diabetes, obesity and neurological diseases will expand the urinary incontinence market. Additionally, high disposable income and increasing trend of non-invasive treatment options will result in the expansion of urinary incontinence market. Along with this, rising geriatric population and rising incidences of chronic diseases will enhance the growth rate of the market. Surge in the consumption of sweeteners, caffeine, carbonated drinks, chocolates, sparkling water, muscle relaxants and artificial chili peppers can enhance the risk of urinary incontinence and hence further projected to cushion the market’s growth rate.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the urinary incontinence market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the urinary incontinence market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the treatment and devices will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies will challenge the urinary incontinence market. Additionally, the dearth of skilled professionals and complications involved with the procedures will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This urinary incontinence market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinary incontinence market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Urinary incontinence market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Urinary Incontinence Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems around the world have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for a variety of reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of urinary incontinence in recent months.

Recent Development

  • In May 2020, Rigicon had announced the launch of two new artificial urinary sphincter models named ContiClassic Artificial Urinary Sphincter and ContiReflex Artificial Urinary Sphincter. AUS stands for Artificial Urine Sphincter and is a medical device used to treat urinary incontinence. When non-surgical and behavioural treatment approaches fail, the Artificial Urinary Sphincter is a surgical treatment option.

Global Urinary Incontinence Market Scope

The urinary incontinence market is segmented on the basis of diagnosis, type, treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnosis

  • Physical Exam
  • Pad Test
  • Urodynamic Testing
  • Cystoscopy
  • Stress Test
  • Ultrasound
  • Urine Samples

Type

  • Stress Incontinence
  • Urge Incontinence
  • Overflow Incontinence

Treatment Type

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Urinary Incontinence Market Regional Analysis/Insights

The Urinary incontinence market is analysed and market size insights and trends are provided by country, diagnosis, type, treatment type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Urinary incontinence market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the urinary incontinence market because of the surging adoption of newer techniques in this region. Additionally, growing presence of major key players and well-established healthcare infrastructure will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to surging number of generic manufacturers and rising government initiatives in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Urinary Incontinence Market Share Analysis

The Urinary incontinence market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to urinary incontinence market.

Some of the major players operating in the urinary incontinence market are:

  • Zydus Cadila (India)
  • Torrent Pharmaceuticals Ltd. (India)
  • Apotex Inc.
  • Eli Lilly and Company (US)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Alembic Pharmaceuticals Limited (India)
  • Coloplast Group (Denmark)
  • Boston Scientific Corporation (US)
  • Alembic Pharmaceuticals Limited (India)
  • B. Braun Melsungen AG (Germany)
  • BD (US)
  • Baxter (US)
  • Johnson & Johnson Private Limited (US)
  • Medtronic (Ireland)
  • AstraZeneca (UK)
  • Merck & Co., Inc. (US) 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The market value for urinary incontinence market is expected USD 19,088.09 million by 2029.
The Urinary Incontinence Market is to grow at a CAGR of 7.30% during the forecast period of 2022 to 2029
The expansion of the Global Urinary Incontinence Market will be fueled by the increased prevalence of urinary incontinence and increasing number of cases of diabetes, obesity and neurological diseases. Additionally, increasing expenditure on healthcare infrastructure and increasing geriatric population will enhance the growth rate of global urinary incontinence market.
The major players operating in the Urinary Incontinence Market are Zydus Cadila (India), Torrent Pharmaceuticals Ltd. (India), Apotex Inc., Eli Lilly and Company (US), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd. (Israel), Alembic Pharmaceuticals Limited (India), Coloplast Group (Denmark), Boston Scientific Corporation (US), Alembic Pharmaceuticals Limited (India), B. Braun Melsungen AG (Germany), BD (US), Baxter (US), Johnson & Johnson Private Limited (US), Medtronic (Ireland), AstraZeneca (UK), Merck & Co., Inc. (US).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials